NEW CASE STUDY Unlocking the power of process analytical technology to boost downstream operations    Dive in today!
Contact Us
Contact Us

Press Releases

Find the latest news on AGC Biologics partnerships, product approvals, site expansions, leadership updates, new programs, and more.

Ben Clauberg appointed VP of Business Development EU

1 min read

AGC Biologics Appointments Ben Clauberg as Vice President, Business Development of European Market

June 14, 2024 at 7:26 AM
Press Release Business Updates
Read press release

1 min read

AGC Biologics & CEO Patricio Massera Announce Plans for Him to Step Down

June 12, 2024 at 12:05 AM
Press Release Business Updates
Read press release
AGC Biologics Copenhagen officially opens their new facility expansion.

2 min read

AGC Biologics Completes Copenhagen Campus Expansion, Doubling Single-use Mammalian Bioreactor Capacity at Site

June 4, 2024 at 12:00 AM
Mammalian & mAbs Press Release Business Updates
Read press release
AGC Biologics is partnering with BioConnection to simplify the path to DP for biologics projects.

2 min read

AGC Biologics and BioConnection Partner to Offer New End-to-End Biopharmaceutical Drug Substance and Drug Product Development and Manufacturing Offering

May 22, 2024 at 3:00 AM
Mammalian & mAbs Press Release Business Updates Microbial
Read press release
Illustration of new AGC Biologics Yokohama Site

1 min read

AGC Biologics selects Cytiva to provide FlexFactory platforms in new biomanufacturing facility in Japan

April 25, 2024 at 5:53 AM
Mammalian & mAbs Press Release Business Updates mRNA Content
Read press release
AGC Biologics and VAR2 Pharmaceuticals Completion of antibody late stage clinical work

1 min read

AGC Biologics Announces Successful Completion of Production of Cancer-Specific Therapeutic Antibody Fragments with Var2 Pharmaceuticals

April 23, 2024 at 8:00 PM
Mammalian & mAbs Press Release Business Updates
Read press release
AGC Biologics CBO, Christoph Winterhalter

2 min read

AGC Biologics Strengthens Executive Leadership with Appointment of Dr. Christoph Winterhalter as Chief Business Officer

March 25, 2024 at 8:23 AM
Press Release Business Updates
Read press release
AGC Biologics Dual FDA Approval

2 min read

AGC Biologics to Manufacture First-ever FDA Approved Gene Therapy for Early-onset MLD, Orchard Therapeutics’ Lenmeldy™

March 18, 2024 at 3:04 PM
Cell & Gene Therapy Press Release Business Updates
Read press release
AGC Biologics new manufacturing facility - Yokohama, Japan

1 min read

AGC Biologics announces plans for New Manufacturing Site in Yokohama Japan

January 4, 2024 at 6:01 AM
Cell & Gene Therapy Mammalian & mAbs Press Release Business Updates mRNA Content
Read press release
New Study: Protein A membrane capture device offers impressive alternative to traditional resin columns.

2 min read

Research: Protein A Capture Technology Offers 10X Productivity Over Standard Resin Columns for Antibody Purification

December 11, 2023 at 8:23 AM
Press Release Business Updates
Read press release
Prev 1 2 3 4 5 Next